pAAV-hSyn-Flpo-3xFLAG
(Plasmid
#173047)
-
PurposeAAV expression of Flpo-3xFLAG by hSyn1 promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 173047 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepAAV
-
Vector typeMammalian Expression, AAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameFlpo
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)1281
- Promoter hSyn1
-
Tag
/ Fusion Protein
- 3xFLAG (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (not destroyed)
- 3′ cloning site HindIII (not destroyed)
- 5′ sequencing primer caaactccccttcccggc
- 3′ sequencing primer atccacatagcgtaaaagga (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byThis construct contains sequences taken from the following plasmids: pAAV-hSyn1-tTA (Addegene, no. 99119), pAAV-EF1a-mCherry-IRES-Flpo (Addgene, no. 55634), and pSF-CMV-NEO-COOH-3XFLAG (Sigma-Aldrich, OGS629).
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV-hSyn-Flpo-3xFLAG was a gift from Kenji Mizuseki (Addgene plasmid # 173047 ; http://n2t.net/addgene:173047 ; RRID:Addgene_173047) -
For your References section:
Intersectional, anterograde transsynaptic targeting of neurons receiving monosynaptic inputs from two upstream regions. Kitanishi T, Tashiro M, Kitanishi N, Mizuseki K. Commun Biol. 2022 Feb 21;5(1):149. doi: 10.1038/s42003-022-03096-3. 10.1038/s42003-022-03096-3 PubMed 35190665